The National Times - Arguments to begin in key US social media addiction trial

Arguments to begin in key US social media addiction trial


Arguments to begin in key US social media addiction trial
Arguments to begin in key US social media addiction trial / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

Arguments are set to begin Monday in a landmark US trial that could establish a legal precedent on whether social media companies deliberately designed their platforms to lead to addiction in children.

Change text size:

The case in Los Angeles Superior Court is being seen as a bellwether proceeding because its outcome could set the tone for a tidal wave of similar litigation across the United States.

Defendants at the trial are Alphabet and Meta, the tech giants behind YouTube and Instagram.

Meta co-founder and chief executive Mark Zuckerberg, along with the bosses of Instagram and YouTube, are expected to be called as witnesses during the trial.

Social media firms are accused in hundreds of lawsuits of leading young users to become addicted to content that has led to depression, eating disorders, psychiatric hospitalization and even suicide.

Lawyers for the plaintiffs are borrowing strategies used in the 1990s and 2000s against the tobacco industry, which faced a similar onslaught of lawsuits arguing that companies sold a harmful product.

On Friday, lawyers for the defense unsuccessfully sought to bar plaintiffs from comparing their platforms to tobacco and other addictive products.

- Profit versus health? -

The trial before Judge Carolyn Kuhl focuses on allegations that a 20-year-old woman identified by the initials K.G.M. suffered severe mental harm because she became addicted to social media as a child.

"This is the first time that a social media company has ever had to face a jury for harming kids," Social Media Victims Law Center founder Matthew Bergman, whose team is involved in more than 1,000 such cases, told AFP.

The center is a legal organization dedicated to holding social media companies accountable for harm allegedly caused to young people online.

Internet titans have argued that they are shielded by Section 230 of the US Communications Decency Act, which frees them of responsibility for what social media users post.

However, this case argues that those firms are culpable for business models designed to hold people's attention and to promote content that can harm their mental health.

"The allegations in these complaints are simply not true," said Jose Castaneda, a YouTube spokesperson.

"Providing young people with a safer, healthier experience has always been core to our work," he added.

Meta has also rejected the allegations.

Snapchat and TikTok were named as defendants in the suit, but struck settlement deals before the start of the trial. The terms were not disclosed.

Lawsuits, including some brought by school districts, accusing social media platforms of practices endangering young users are making their way through federal court in northern California and state courts across the country.

A separate lawsuit accusing Meta of putting profit over the wellbeing of young users is also getting under way in New Mexico.

"Our investigation into Meta's social media platforms demonstrates that they are not safe spaces for children but rather prime locations for predators to trade child pornography and solicit minors for sex," New Mexico Attorney General Raul Torrez said in a statement.

Meta has rejected the accusations and vowed to defend itself in court.

Jury selection in the Los Angeles case ended on Friday, with Meta dismissing several jurors over their strong opinions about either social media in general or Zuckerberg specifically.

P.Sinclair--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: